net income $5.58B. Morgan Stanley Q2 2026: Net revenues +57.7%, EPS +62%, ROE 20.7%

Filed August 4, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 4, 2025 · ~2 min read

Key Changes

• high

  Diluted EPS surged 62% to $3.46 from $2.13, accelerating sharply from 17% growth in the prior year quarter, driven by higher revenues and improved operating leverage (expense efficiency ratio 65% vs. 71%).

  MD&A: Earnings per diluted share verify on EDGAR →
• high

  Net revenues rose 27% to $21.3 billion from $16.8 billion, with Institutional Securities up 44% to $11.0 billion (Equity +69%, Investment Banking +58%) and Wealth Management up 14% to $8.9 billion.

  MD&A: Net revenues verify on EDGAR →
• high

  ROE improved to 20.7% from 13.9% and ROTCE to 26.6% from 18.2%, both exceeding the firm's 20% ROTCE goal, reflecting higher profitability and efficient capital deployment.

  MD&A: Return on equity verify on EDGAR →